login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
IOVANCE BIOTHERAPEUTICS INC (IOVA) Stock News
USA
- NASDAQ:IOVA -
US4622601007
-
Common Stock
2.205
USD
-0.1 (-4.55%)
Last: 10/28/2025, 3:14:59 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IOVA Latest News, Press Relases and Analysis
All
Press Releases
5 days ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025
11 days ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
11 days ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
11 days ago - By: The Motley Fool
- Mentions:
TDOC
Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health
2 months ago - By: Stocktwits
- Mentions:
VFMO
IWMW
Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’
15 days ago - By: The Motley Fool
Is Iovance Biotherapeutics Stock Your Ticket to Becoming a Millionaire?
20 days ago - By: Bragar Eagel & Squire
IOVANCE (IOVA) ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Iovance Biotherapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
a month ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
a month ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2 months ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics to Present at Upcoming Conferences
2 months ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics to Present at Upcoming Conferences
2 months ago - By: Zacks Investment Research
- Mentions:
MRK
ANIP
CRMD
IOVA Stock Drops 6% on $350M Common Stock Offering
2 months ago - By: Yahoo Finance
Why Iovance Biotherapeutics Stock Got Mashed on Monday
2 months ago - By: Benzinga
- Mentions:
AXGN
AMBR
GCT
KDP
...
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday
2 months ago - By: Yahoo Finance
Artisan Small Cap Fund Exited Its Stake in Iovance Biotherapeutics (IOVA) Due to Operational Challenges
2 months ago - By: Yahoo Finance
1 Beaten-Down Stock That Could Soar By 261%, According to Wall Street
2 months ago - By: Yahoo Finance
Iovance Biotherapeutics (IOVA) Receives Conditional Approval From Health Canada
2 months ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2 months ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2 months ago - By: Benzinga
- Mentions:
HTLD
INTC
SAIA
SSYS
...
Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday
2 months ago - By: Iovance Biotherapeutics, Inc.
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
2 months ago - By: Iovance Biotherapeutics, Inc.
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
Please enable JavaScript to continue using this application.